Trials / Suspended
SuspendedNCT00921635
A Study to Evaluate the Impact of Maintaining Hemoglobin Levels in Anemic Patients With Carcinoma of the Cervix
A Phase III Study to Evaluate the Impact of Maintaining Haemoglobin Levels Above 120g/L Verses Above 100g/L in Anaemic Patients With Carcinoma of the Cervix Receiving Concurrent Cisplatin and Radiation Therapy
- Status
- Suspended
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- Tri-Service General Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the feasibility, safety and short term effects on health related quality of life, of maintaining hemoglobin from 120 to 130 g/L versus from 100 to 110 g/L, with red cell concentrate (RCC) transfusion, in women having chemo-radiation for cancer of the cervix.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Blood transfusion | Blood transfusion to maintain hemoglobin level above 120 g/L |
| PROCEDURE | Blood transfusion | Blood transfusion to maintain hemoglobin level above 100 g/L |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2011-05-01
- First posted
- 2009-06-16
- Last updated
- 2009-06-19
Source: ClinicalTrials.gov record NCT00921635. Inclusion in this directory is not an endorsement.